
QUBIS
Description
QUBIS (Queen's University Belfast Intellectual Property and Spin-out Company) serves as the dedicated commercialization arm of Queen's University Belfast, a leading research institution in the United Kingdom. Its core mission is to proactively identify, protect, and facilitate the commercial exploitation of groundbreaking research and intellectual property generated within the university. By bridging the gap between academic innovation and market opportunity, QUBIS plays a pivotal role in transforming cutting-edge discoveries into viable businesses. This strategic focus ensures that the university's intellectual assets contribute significantly to economic development and societal benefit, particularly within Northern Ireland and beyond.
QUBIS primarily functions as an early-stage investor, providing crucial seed capital to high-growth potential spin-out companies directly emerging from Queen's University. Their investment strategy is deeply intertwined with the university's research strengths, encompassing sectors such as life sciences, deep technology, engineering, information technology, and advanced manufacturing. QUBIS often acts as the foundational investor, frequently co-investing alongside other venture capital firms, angel investors, and government-backed funds to build robust funding rounds. This collaborative approach helps de-risk early ventures and provides the necessary runway for these nascent companies to develop their products, scale operations, and attract further investment.
Since its inception, QUBIS has demonstrated a significant impact on the innovation ecosystem, having successfully supported the creation and growth of over 100 spin-out companies. These ventures span a diverse range of industries, showcasing the breadth of research excellence at Queen's University. Beyond initial capital, QUBIS provides comprehensive support, including business development, strategic guidance, and access to networks, which are vital for early-stage success. The organization's efforts have been instrumental in attracting substantial follow-on investment for its portfolio companies, collectively securing over £200 million (approximately $252 million USD) in external capital, further validating the commercial potential of Queen's University's research.
While specific check sizes can vary depending on the stage and needs of the spin-out, QUBIS typically provides initial seed investments ranging from approximately $60,000 to $600,000. These first cheques are designed to help companies achieve critical milestones, such as proof-of-concept, prototype development, or initial market validation. QUBIS's commitment extends beyond financial backing, fostering a vibrant entrepreneurial culture within the university and contributing significantly to the regional economy by creating high-value jobs and fostering innovation-driven growth. Their unique position as an embedded university investor allows them to identify and nurture promising ventures from their earliest conceptual stages.
Investor Profile
QUBIS has backed more than 40 startups, with 4 new investments in the last 12 months alone. The firm has led 6 rounds, about 15% of its total and boasts 6 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States.
- Strong thematic focus on Health Care, Biotechnology, Medical.
- Typical check size: $60K – $600K.
Stage Focus
- Seed (43%)
- Series Unknown (43%)
- Series A (5%)
- Series B (3%)
- Pre Seed (3%)
- Private Equity (3%)
- Grant (3%)
Country Focus
- United Kingdom (95%)
- United States (5%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Therapeutics
- Software
- Information Technology
- Medical Device
- Health Diagnostics
- Artificial Intelligence (Ai)
- Pharmaceutical
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.